Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) major shareholder Robert Williams, Jr. sold 2,250,000 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $11.50, for a total value of $25,875,000.00. Following the completion of the sale, the insider owned 12,315,892 shares in the company, valued at approximately $141,632,758. This represents a 15.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.
Aveanna Healthcare Price Performance
AVAH stock traded up $0.54 during trading on Monday, hitting $13.70. The company had a trading volume of 5,371,630 shares, compared to its average volume of 1,804,159. The company has a fifty day moving average price of $9.58 and a two-hundred day moving average price of $7.92. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $13.98. The company has a market cap of $2.99 billion, a P/E ratio of 11.14, a P/E/G ratio of 0.92 and a beta of 1.90. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47.
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last released its quarterly earnings data on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.05. The firm had revenue of $670.48 million during the quarter, compared to analyst estimates of $638.61 million. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%. Equities research analysts expect that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current fiscal year.
Key Headlines Impacting Aveanna Healthcare
- Positive Sentiment: Royal Bank of Canada raised its price target for Aveanna Healthcare from $10 to $16 and upgraded the stock to “outperform.” The new target implies additional upside from recent trading levels, providing a bullish signal for AVAH. Benzinga analyst price-target report
- Neutral Sentiment: Truist Financial increased its price target from $11 to $15 but maintained a “hold” rating. The higher valuation suggests improved expectations, while the unchanged rating indicates the firm does not see a compelling reason to become more bullish after the stock’s recent advance. Benzinga analyst price-target report
- Negative Sentiment: Several insiders sold a combined 320,000 shares at an average price of $11.50, generating approximately $3.68 million. CEO Jeff Shaner sold 90,000 shares, director Rodney D. Windley sold 180,000, and insider Edwin C. Reisz sold 50,000. Each retained a substantial stake, but the coordinated sales—particularly Windley’s roughly 8% position reduction—could raise concerns about insider confidence or add near-term selling pressure. CEO insider sale filing Director insider sale filing Insider sale filing
Institutional Investors Weigh In On Aveanna Healthcare
A number of hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new position in shares of Aveanna Healthcare in the second quarter worth about $63,504,000. Vanguard Group Inc. lifted its position in shares of Aveanna Healthcare by 38.0% during the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after purchasing an additional 1,535,351 shares in the last quarter. Braidwell LP grew its stake in shares of Aveanna Healthcare by 39.1% during the second quarter. Braidwell LP now owns 3,065,106 shares of the company’s stock valued at $26,268,000 after purchasing an additional 861,600 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Aveanna Healthcare by 17.7% in the fourth quarter. Geode Capital Management LLC now owns 1,849,057 shares of the company’s stock valued at $15,110,000 after purchasing an additional 278,429 shares in the last quarter. Finally, Nuveen LLC increased its holdings in shares of Aveanna Healthcare by 135.9% in the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock valued at $12,838,000 after purchasing an additional 905,316 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.
Analyst Ratings Changes
Several equities analysts recently issued reports on the stock. Wall Street Zen downgraded shares of Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. UBS Group raised their price objective on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a report on Friday, August 14th. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $10.00 to $11.00 in a research note on Friday, May 15th. Barclays boosted their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a report on Thursday, July 9th. Finally, Raymond James Financial increased their price target on Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $12.89.
View Our Latest Stock Analysis on Aveanna Healthcare
Aveanna Healthcare Company Profile
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
Featured Articles
- Five stocks we like better than Aveanna Healthcare
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
